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Introduction 
Frequently, the diagnosis of cervical cancer is made at an early stage particularly as 
tumors detected at screening are of smaller volume than those identified in women 
who present with vaginal bleeding [1]. Often, the cone or large loop excision of the 
transformation zone (LLETZ) biopsy on which the diagnosis is made and which leads 
to routine use of T2-W magnetic resonance imaging for assessing disease extent 
within the cervix [2], removes a large amount of the disease. The determination of 
residual disease is crucial in treatment planning; fertility-sparing procedures demand 
a precise knowledge of the site and extent of any residual disease in order to ensure 
a curative and optimal surgical strategy. However, even with the use of an 
endovaginal coil to improve spatial resolution [3], image contrast between tumor and 
surrounding granulation tissue following cone biopsy can be insufficient [4] to 
delineate the extent of residual disease within the cervix, particularly when disease 
involves the margins of the cone. This has lead to investigation into alternative 
contrast mechanisms for identifying tumor. 
The use of intrinsic contrast mechanisms such as diffusion-weighted imaging is 
proving useful in a variety of extra-cranial cancer related 
pathologies [5], [6], [7], [8] and [9]. Diffusion-weighted (DW)-MRI is sensitive to the 
motion of water within tissues of the order of 10–20 μm [10]. Application of a series 
of diffusion sensitizing gradients allows calculation of an apparent diffusion 
coefficient (ADC) for each pixel in the image which is then represented as a map. 
Tumors generally appear as areas of relatively restricted diffusion, compared to non-
tumor regions and histopathological correlations have indicated that this is largely a 
function of cell density, with limited extracellular space limiting water diffusivity [11]. 
In the cervix, pilot data has documented values for ADC within tumor and 
surrounding non-tumor tissue and indicated good sensitivity for separating them 
based on ADC [12]. The purpose of this study therefore was to evaluate the effect of 
previous cone biopsy and lesion size on the accuracy of detection of Stage 1a/1b 
cervical cancer using endovaginal T2- and diffusion-weighted magnetic resonance 
imaging. 
Materials and methods 
Patients 
This was a prospective, single-institution study with approval from the local research 
ethics committee. Written informed consent was obtained from each subject. 
Patients unsuitable for MR imaging because of metallic implants or claustrophobia 
were excluded. No account was taken of stage of menstrual cycle. Over a 3-year 
period (July 2007 to July 2010) 113 women with previously diagnosed cervical 
cancer were recruited prospectively to this study by gynaecologists in the clinic and 
subsequently had MR imaging performed on a 1.5-T MRI scanner (Intera; Philips, 
Best, the Netherlands) using a 37-mm ring coil [13] designed specifically to image 
the cervix. Of these, 2 were subsequently diagnosed with endometrial cancer, 22 
women were upstaged and required chemotherapy and/or radiotherapy rather than a 
primary surgical approach, 3 patients were found not to have invasive cancer on 
histological review and 1 patient became pregnant soon after diagnosis and required 
conservative management. These 28 women were excluded from the study. Of the 
85 women (aged, 23–74; median, 34 years), 58 had cone or LLETZ biopsy 
performed prior to imaging (median, 35 days; 11–125 days; interquartile range, 25), 
the remaining 27 patients having had their cancer previously confirmed by less 
invasive methods of biopsy (e.g. punch biopsy, curettage). After MR imaging 24 
were treated conservatively (extended cone biopsy/LLETZ/colposcopic follow-up), 30 
had trachelectomy and 31 had radical hysterectomy (2 of whom had neoadjuvant 
chemotherapy). 
Imaging methods 
Images were obtained on a 1.5-T Philips Intera using a 37 mm ring design solenoidal 
receiver coil that has been previously described. The coil was inserted following 
digital vaginal examination and positioned around the cervix. Air in the vagina 
introduced during coil insertion was aspirated via a 4 mm diameter tube (Ryles; 
Pennine Healthcare, London, England) to reduce susceptibility-based artifacts 
occurring at the air–tissue interface. Each patient was examined supine and coil 
immobilization achieved using an externally sited clamp whose stand was placed 
under the patients’ knees. Hyoscine butyl bromide 20 mg was administered routinely 
intramuscularly to reduce artefact from bowel motion. 
T2-W images (repetition time ms/echo time ms, 4500/80; acquisition matrix, 256; 
field of view, 11 cm; section thickness, 3 mm; no intersection gap) were obtained in 
three orthogonal planes to the cervix [sagittal, coronal and transverse] with a 
0.43 mm in-plane resolution and 0.55 mm3 voxel size. Single-shot diffusion-weighted 
echo-planar images (TR/TE 2500/69 ms; matrix, 96, reconstructed to 128; field of 
view, 20 cm) employing b-values of 0, 100, 300, 500, and 800 s/mm2 were obtained 
in the coronal plane to match the T2-W images. Twelve 4-mm-thick sections 
provided coverage of the cervix (acquisition time 1 min 24 s, in-plane resolution 
2.1 mm, voxel size 17.6 mm3). Isotropic ADC maps were generated with the system 
software using all b-values and an average value for the three directions of diffusion 
sensitization. Following endovaginal imaging, the internal receiver coil was removed 
and axial images through the abdomen and pelvis obtained for assessment of lymph 
node status which did not form part of this study. 
Image analysis 
All images were evaluated prospectively at the time of reporting using all available 
clinical information by a single gynaecological radiologist with > 10 years experience 
of endovaginal MRI. Images were scored in a binary fashion as positive or negative 
for the presence of tumor based on the combined information from T2-W and DW 
images viewed together. Images were deemed to be positive for tumor if there was a 
mass lesion (definite tumor) or nodularity (high index of suspicion) on T2-W imaging 
with corresponding diffusion restriction on the ADC map. Images were deemed to be 
negative for tumor if there was no mass (definitely negative) or nodularity (low index 
of suspicion) on T2-W imaging with no corresponding diffusion restriction on the 
ADC map. In patients scored positive for invasive disease, tumor volume was 
measured by drawing a region of interest around the tumor on the T2-W images on 
every slice containing the lesion, and multiplying the summed area on all slices by 
slice thickness. Maximum radiological dimensions of the tumor visualised in 
superior–inferior, anterior–posterior and right–left directions also were noted on T2-
W images. 
On the ADC maps, using visual correlation with anatomic information on the 
corresponding T2-W image, a slice with the largest tumor area with adjacent cervical 
epithelium visible was selected, and regions of interest encompassing the entire 
tumor drawn around the lesion and normal cervical epithelium. In those without 
visible cervical epithelium, the slice with the largest tumor dimensions was used. 
Histopathological analysis 
Trachelectomy and hysterectomy sectioning was carried out in the standard manner 
for our institution. Section thickness was 4 mm. The cervix was sectioned 
transversely from the internal os caudally to a level approximately 1 cm from the 
ectocervix. The inferior part of the cervix and vaginal cuff was then sliced serially in a 
sagittal/parasagittal plane; the lateral ends were in turn sliced serially in a coronal 
plane. Thus, sections anterior and posterior related to MR images acquired in the 
sagittal plane, while lateral sections related to coronal MR images. For conisation 
samples, sections were sliced serially in a sagittal/parasagittal plane starting at the 3 
or 9 o'clock end. The lateral end-slices were often embedded whole, as they were 
too small to slice serially in the coronal plane. 
Statistical analysis 
Statistical analysis used SPSS for Windows v 18.0 and tested for normality using a 
Shapiro-Wilk test. Mann-Whitney U was used for comparisons of non-normally 
distributed data. Sensitivity, specificity, positive and negative predictive values of T2-
W combined with DW-MRI in distinguishing tumor was established for patients 
without versus those with previous cone biopsy/LLETZ. Area under receiver 
operating characteristic (ROC) curve (Az) was used to determine the cut-off lesion 
volume measured on MRI for best accuracy in identifying the presence of residual 
invasive disease and cut-off lesion size (maximum dimension on histopathology in all 
positive cases) for best accuracy in identifying disease on MRI in patients without 
and with previous cone biopsy/LLETZ. Maximum MR tumor dimension measured on 
T2-W images was correlated with maximum tumor dimension on histology using 
Spearman's rho. 
In patients with definite radiological and histological evidence of tumor, ADC values 
from tumor regions of interest (ROIs) were compared with those of adjacent cervical 
epithelium using a paired t-test after log transformation of non-normally distributed 
data. ADC values of tumor and normal epithelium were compared between the two 
groups using a Mann-Whitney U test. A p value of less than .05 was used to indicate 
significance. 
Results 
The procedure was tolerated well in all subjects and in no case was termination of 
the examination requested by any patient. There was no significant difference in age 
between the 27 patients without (median 36 years, lower quartile [LQ] 28 years, 
upper quartile [UQ] 45 years) and 58 patients with prior cone biopsy/LLETZ (median 
33 years, LQ 29 years, UQ 39 years, p = 0.18). 
In the 27 patients who had not undergone cone biopsy/LLETZ prior to imaging, 26 
were classed as definite disease (Fig. 1) and 1 as low suspicion of disease. In 58 
patients with cone biopsy/LLETZ prior to imaging 24 were classed as definite 
(n = 15 Fig. 2) or a high suspicion (n = 9) of residual invasive disease and scored 
positive for tumor on imaging. Thirty-four were classed as either no disease (n = 5) 
or low suspicion of disease (n = 29) and were scored negative radiologically. 
Sensitivity, specificity, positive and negative predictive values for identifying tumor in 
patients without and with cone biopsy is given inTable 1. 
 Fig. 1.  
Cervical cancer in a 28-year-old female with no cone biopsy or LLETZ prior to 
MRI: sagittal (A), axial (B) and coronal (C) T2-W images using an endovaginal 
coil show a 200 mm3 (8 mm maximum dimension) lesion (arrows) on the right 
anterior cervical lip which, on the coronal ADC map (D) in the same slice 
position as (C), shows markedly restricted diffusion (arrow). A LLETZ biopsy 
following MRI (E) confirmed a 9 mm tumor nodule (arrow). 
Figure options 
 Fig. 2.  
Cervical cancer in a 38-year-old female with cone biopsy or LLETZ prior to 
MRI: sagittal (A), axial (B) and coronal (C) T2-W images using an endovaginal 
coil show a concave LLETZ defect with an irregular 150 mm3 (17 mm 
maximum dimension) lesion (arrows) at the transformation zone which, on the 
coronal ADC map (D) in the same slice position as (C), shows markedly 
restricted diffusion (arrow). A hysterectomy following MRI (E) confirmed a 30 
mm tumor plaque (arrow). 
Figure options 
Table 1. 
Sensitivity, specificity, positive and negative predictive values for identifying 
invasive cervical carcinoma using T2-W and ADC maps in patients without or 
with previous cone biopsies (TP = true positive, TN = true negative, FP = false 
positive, FN = false negative, PPV = positive predictive value, NPV = negative 
predictive value). 
 TP TN FP FN Sensitivity 
% 
Specificity 
% 
PPV 
% 
NPV 
% 
Cone 
(n = 58) 
16 30 8 4 80.0 78.9 66.7 88.2 
No cone 
(n = 27) 
26 1 0 0 100 100 100 100 
Table options 
Median tumor volume on the T2-W images in all 50 cases scored positive on 
imaging was 900 mm3 (LQ 200 mm3, UQ 4200 mm3), maximal lesion dimension 
15.4 mm (LQ 8.6 mm, UQ 25.8 mm). All cases without prior cone biopsy/LLETZ 
were correctly scored; the smallest tumor volume was 200 mm3 and the smallest 
untreated maximum dimension on histology was 8 mm. In those with prior cone 
biopsy/LLETZ a cut-off volume of 83 mm3 (approximately 150 T2-W voxels) detected 
tumor with 80.0% sensitivity and 94.7% specificity (Az = 0.86; Fig. 3). 
 
Fig. 3.  
ROC curve of MRI-derived tumor volume in patients who had cone 
biopsy/LLETZ prior to MRI gives an area under the curve (Az) of 0.86. 
Figure options 
Of 46 patients with residual disease on histology, 2 had received neoadjuvant 
chemotherapy so were not included in the histological dimension analysis. Median 
maximal dimension of tumors on histology in the remaining 44 (25 without and 19 
with prior cone biopsy/LLETZ) was 20 mm (LQ 10.8 mm, UQ 30.5 mm). An 
independent samples t-test demonstrated a significant difference in maximum tumor 
dimension on pathology in those without (mean ± standard deviation 
25.5 ± 13.8 mm) and with (mean ± standard deviation 14.9 ± 9.9 mm) previous cone 
biopsy/LLETZ (p = 0.007). In patients with prior cone biopsy/LLETZ, a cut-off value 
of 3 mm maximal histological tumor dimension was detected on MR with 100% 
sensitivity, 75% specificity; at 5.3 mm, 100% sensitivity and specificity was achieved 
(Az = 1). The maximum dimension on histopathology in those with prior cone 
biopsy/LLETZ was significantly larger in those with a true positive result (7.5–35 mm) 
than those with a false negative result (1–3 mm) (p = 0.003), although the time 
interval between prior cone biopsy/LLETZ and imaging was not statistically 
significant between these groups (p = 0.42). 
Maximal tumor dimension in the 48 MRI positive patients managed surgically without 
neoadjuvant chemotherapy showed significant positive correlation with histological 
dimensions (rs = 0.78, p < 0.001) which remained so when the groups were 
considered separately (no previous cone biopsy/LLETZ n = 25, rs = 0.79, p < 0.001; 
with previous cone biopsy/LLETZ n = 23, r = 0.73, p < 0.001). 
Of the 50 patients with positive radiological diagnosis, 42 had histological evidence 
of tumor and it was possible to identify tumor and normal epithelium on the T2-W 
images in 41. ADCs of invasive cervical carcinoma (median 988, LQ 869, UQ 
1101 × 10−6 mm2/s) and paired normal epithelial tissue (median 1564, LQ 1430, UQ 
1694 × 10−6 mm2/s) were significantly different (p < 0.001) but tumor or cervical 
epithelial ADCs did not differ significantly between patients who had not (n = 26 and 
25, respectively) and those who had (n = 16) prior cone biopsy/LLETZ (p = 0.48 and 
0.15 respectively, Fig. 4). Of the patients with prior cone biopsy, ADCs of tissue 
identified as tumor in the 8 false positive patients (median 1210, LQ 1135, UQ 
1303 × 10−6 mm2/s) were significantly higher than tumor ADCs in the 16 true positive 
patients (median 1011, LQ 906, UQ 1175 × 10−6 mm2/s) (p = 0.007). 
 Fig. 4.  
ADC values of invasive cervical carcinoma and adjacent normal appearing 
epithelium in patients without (dark grey) and with (light grey) cone 
biopsy/LLETZ prior to endovaginal T2- and diffusion-weighted MRI show 
significant differences between tumor and normal appearing epithelium in 
both groups. However, tumor values and normal appearing epithelial values 
are similar between groups. Median (middle line of box), quartiles (lower and 
upper lines of box), and extreme values (lower and upper whiskers). 
Figure options 
Discussion 
This study establishes the sensitivity and specificity of detecting cervical tumor using 
T2-W and diffusion-weighted MRI with an endovaginal receiver coil in patients 
without and with a cone biopsy or LLETZ procedure prior to MRI and demonstrates a 
lower accuracy in the latter. In current practice, most patients are subject to a “see 
and treat” approach, where they undergo routine outpatient cone biopsy or LLETZ 
procedure if an abnormality is detected at colposcopy. In these circumstances, 
granulation tissue and scarring post-procedure which creates intermediate signal 
intensity on T2-W images can cause diagnostic difficulty and requires the addition of 
the ADC map to help differentiate tumor. However, echo-planar diffusion-weighted 
sequences are subject to susceptibility artefacts from blood and air within potential 
surgical defects which create errors in interpretation. Despite the lower sensitivity 
compared to patients without previous cone biopsy/LLETZ, the sensitivity and 
specificity for diagnosing lesions as small as 200 mm3was acceptable compared to 
standard external array MRI of much larger lesions [14]. Although the accuracy of 
the technique is higher in patients without a previous cone biopsy/LLETZ the 
alternative of scanning of a large number of colposcopically abnormal women 
without definite invasive disease is not practicable. 
The sensitivity and specificity with which the radiological assessment could correctly 
detect tumors with a cut-off size of 5 mm on subsequent histological specimens in 
patients with prior cone biopsy/LLETZ, indicates that this technique is a useful 
diagnostic technique prior to fertility-sparing surgery where measurement of the 
maximal tumor dimensions, particularly the estimation of extent within the 
endocervical canal, is crucial for surgical planning [15]. Correlation of maximum 
tumor dimension as visualised on T2-W MRI and that subsequently determined on 
histology was good regardless of prior cone biopsy/LLETZ despite the fact that some 
tumor configurations (e.g. a thin, flat plaque) may be associated with a large 
maximum tumor dimension but small tumor volume and hence more difficult to 
visualize radiologically. Because of the varying orientations of the histological 
sections and the MRI scans, a maximal dimension from each technique was used for 
comparison. In future, a volume-based MRI acquisition technique may enable more 
accurate orientation of the MRI abnormality with the histology. 
The ADCs of tumor remained significantly different to that of adjacent normal 
epithelium independent of the existence of a prior cone biopsy. This extends the 
finding from previous work where we have shown that the ADC values of cervical 
tumor are significantly lower than surrounding normal tissue [12]. Interestingly there 
was no significant difference in normal epithelium in patients with previous cone 
biopsy compared to those without, despite the likelihood that such a procedure 
would disrupt the normal epithelium. With a median time between cone biopsy and 
MR scanning of ~ 30 days it is feasible that much of the acute reaction to injury may 
have subsided by the time the scan was performed. 
The success of a T2- plus diffusion-weighted diagnostic approach is necessarily 
limited by the resolution achievable with our current diffusion-weighted sequence 
(2.1 mm in-plane, 17.6 mm3 voxel size). Although the maximum dimensions on 
histology of the false negative tumors were 3 mm, shrinkage is likely during 
histological fixation and has been estimated at 15% for cervical tissue [16], so that 
these tumors may have occupied less than 3 voxels on a diffusion-weighted image 
and resulting ADC values increased through partial volume effects. It may be 
possible to reduce the false negative rate in patients with previous cone biopsy by 
improvements in spatial resolution of the technique whilst maintaining an appropriate 
signal-to-noise ratio. This may be afforded by scanning patients at a higher field 
strength, increasing the sequence scan time or using fewer b-values whilst 
increasing the number of signal averages. 
False positive results on the other hand, are likely to arise from effects of residual 
blood products [12]. Granulation tissue itself is highly vascularised and may have 
contributed to significantly higher ADCs in tissue identified as tumor in the false 
positive group compared to the true positives in the post cone biopsy cohort. There 
were no false positives or negatives associated with patients who had not undergone 
a previous cone biopsy/LLETZ, which shows superiority to quoted values for 
standard external array techniques [17]. 
A limitation to this study is that, whilst prospective, a single experienced operator 
reported all images immediately after data acquisition and prior to any surgery, and 
therefore the study did not benefit from intraobserver data. Our previous 
study [12]indicated that the inclusion of ADC maps resulted in good intraobserver 
agreement. In future a multicentre prospective study should establish whether such 
an observation holds for multiple observers in a larger group of patients. 
In investigating the effects of a cone biopsy/LLETZ prior to MR imaging we did not 
differentiate between the two methods despite a potential difference in the type of 
trauma associated with the two techniques [18] and [19]. As an initial investigation 
into the impact of significant tissue removal prior to an MR examination it was 
thought more appropriate to combine the two types of biopsy in the analysis. 
Investigating the potentially different impacts of the two approaches on the 
subsequent accuracy of MR diagnoses will form the basis of further investigation. 
Such future work and the improvement of the spatial resolution of the diffusion-
weighted MR sequence has the potential to further improve the management of 
women diagnosed with cervical cancer who wish to be considered for conservative 
fertility-sparing surgery. 
In summary, a combination of T2-W with diffusion-weighted imaging using an 
endovaginal technique is invaluable for detecting small cervical cancers, prior to 
fertility-sparing procedures although sensitivity and specificity are lower following a 
previous cone biopsy/LLETZ procedure. However, the size of tumors detected even 
post cone/LLETZ is of the order where fertility-sparing surgery remains a major 
management option. This procedure remains to be evaluated in multicentre trials, but 
offers enormous potential in the pre-operative management of this group of patients. 
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